Your browser doesn't support javascript.
loading
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
Manz, Xue D; Szulcek, Robert; Pan, Xiaoke; Symersky, Petr; Dickhoff, Chris; Majolée, Jisca; Kremer, Veerle; Michielon, Elisabetta; Jordanova, Ekaterina S; Radonic, Teodora; Bijnsdorp, Irene V; Piersma, Sander R; Pham, Thang V; Jimenez, Connie R; Vonk Noordegraaf, Anton; de Man, Frances S; Boon, Reinier A; Voorberg, Jan; Hordijk, Peter L; Aman, Jurjan; Bogaard, Harm Jan.
Afiliação
  • Manz XD; Department of Pulmonary Medicine and.
  • Szulcek R; Department of Pulmonary Medicine and.
  • Pan X; Institute of Physiology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin and German Heart Center Berlin, Germany.
  • Symersky P; Department of Pulmonary Medicine and.
  • Dickhoff C; Department of Cardio-thoracic Surgery.
  • Majolée J; Department of Cardio-thoracic Surgery.
  • Kremer V; Department of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Michielon E; Department of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Jordanova ES; Department of Molecular Cell Biology and Immunology, and.
  • Radonic T; Center for Gynecologic Oncology Amsterdam, and.
  • Bijnsdorp IV; Department of Pathology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.
  • Piersma SR; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
  • Pham TV; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
  • Jimenez CR; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
  • Vonk Noordegraaf A; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
  • de Man FS; Department of Pulmonary Medicine and.
  • Boon RA; Department of Pulmonary Medicine and.
  • Voorberg J; Department of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Hordijk PL; Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands.
  • Aman J; Department of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Bogaard HJ; Department of Pulmonary Medicine and.
Am J Respir Crit Care Med ; 205(7): 806-818, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35081007
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Hipertensão Pulmonar Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Hipertensão Pulmonar Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article